Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Hansa Biopharma AB

Closing information (x1000 SEK)

Closing information 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Turnover 154,525 Less Arrow 33,878 Less Arrow 6,098
Financial expenses 48,639 Less Arrow 1,219 Less Arrow 257
Earnings before taxes -609,979 More Arrow -548,130 More Arrow -420,893
EBITDA -588,588 More Arrow -546,978 More Arrow -415,141
Total assets 1,687,406 Less Arrow 1,012,808 More Arrow 1,434,496
Current assets 1,604,704 Less Arrow 942,342 More Arrow 1,393,387
Current liabilities 264,714 Less Arrow 171,219 Less Arrow 114,203
Equity capital 602,911 More Arrow 757,573 More Arrow 1,242,124
- share capital 55,034 Less Arrow 46,335 Less Arrow 41,448
Employees (average) 144 Less Arrow 116 Less Arrow 82

Financial ratios

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Solvency 35.7% More Arrow 74.8% More Arrow 86.6%
Turnover per employee 1,073 Less Arrow 292 Less Arrow 74
Profit as a percentage of turnover -394.7% Less Arrow -1618.0% Less Arrow -6902.1%
Return on assets (ROA) -33.3% Less Arrow -54.0% More Arrow -29.3%
Current ratio 606.2% Less Arrow 550.4% More Arrow 1220.1%
Return on equity (ROE) -101.2% More Arrow -72.4% More Arrow -33.9%
Change turnover 120,647 Less Arrow 27,780 Less Arrow 2,734
Change turnover % 356% More Arrow 456% Less Arrow 81%
Chg. No. of employees 28 More Arrow 34 Less Arrow 19
Chg. No. of employees % 24% More Arrow 41% Less Arrow 30%

Total value of public sale

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.